Bloomberg BNA Publishes 2012 Cumulative Supplement to “Patent Infringement Remedies”

Arlington, Va. (August 2012) — Bloomberg BNA today announces the publication of the 2012 Cumulative Supplement to Patent Infringement Remedies, offering updated analysis of significant remedies issues and providing a new glossary of terms commonly used in the discussions of patent infringement remedies.

Patent Infringement Remedies is a groundbreaking resource on recovery for patent infringement that includes topical consideration of lost profit determinations; reasonable royalty damages determinations, including the Georgia-Pacific factors to be considered in calculating reasonable royalty; preliminary and permanent injunctions; willful infringement and exceptional case findings; the award of enhanced damages and attorneys’ fees; the award of interest and costs; limitations on damages recovery, including the §286 bar and marking; and special remedial provisions.

The 2012 Cumulative Supplement includes treatment and discussion of important recent cases, including:

• Aero Prods. Int’l, Inc. v. Intex Rec. Corp. and duplicative recovery 
• Poly America, L.P. v. GSE Lining Technology, Inc. and lost profits
• Uniloc USA, Inc. v. Microsoft Corp. and reasonable royalties
• In re Seagate Technology, LLC and enhanced damages and willful infringement
• eBay, Inc. v. MercExchange and injunctive relief
• In re Seagate Technology and willfulness and exculpatory opinions of counsel
• Quanta Computer, Inc. v. LG Elecs., Inc. and licensing

The Supplement further enhances the analytical discussion of the applicable remedial theories introduced in the main volume and forecasts likely trends. These considerations draw on the author’s distillation of the insights and experiences of numerous patent practitioners and members of the judiciary.

The author of Patent Infringement Remedies, 2012 Cumulative Supplement is Lawrence M. Sung, a partner in the international law firm of Baker Hostetler LLP, Washington, DC, who specializes in biotechnology, medical device, and pharmaceutical patent counseling, and litigation and technology transfers. He also is a Professor and Director of the Intellectual Property Law Program at the University of Maryland School of Law. His background includes a judicial clerkship with the U.S. Court of Appeal for the Federal Circuit, as well as a Ph.D. in microbiology. This title is available for sale directly from Bloomberg BNA and is also available on the Bloomberg Law legal research system.

# # #